NCT05212948View on ClinicalTrials.gov

A Study of S-268019 for the Prevention of COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

9,902

Participants

Timeline

Start Date

December 25, 2021

Primary Completion Date

December 19, 2022

Study Completion Date

July 19, 2023

Conditions
SARS-CoV-2
Interventions
DRUG

S-268019-b

Solution for IM injection

DRUG

Placebo

Saline solution for IM injection

Trial Locations (1)

Unknown

Buon Ma Thuot City Medical Center, Buon Ma Thuot

Sponsors

Lead Sponsor

Shionogi
All Listed Sponsors
lead

Shionogi

INDUSTRY